Dordaviprone is an organic heterotricyclic compound, specifically 2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, substituted with 2-methylbenzyl at position 4 and benzyl at position 7. It acts as a selective dopamine receptor D2 antagonist and an allosteric agonist of mitochondrial protease caseinolytic protease P. It functions as an antineoplastic agent, dopamine receptor D2 antagonist, and apoptosis inducer. It belongs to toluenes, benzenes, and organic heterotricyclic compounds.
